Journal of ShanDong First Medical University&ShanDong Academy of Medical Sciences››2024,Vol. 45››Issue (4): 251-256.DOI:10.3969/j.issn.2097-0005.2024.04.011
• Reviews •Previous Articles
Received:
2023-11-28Online:
2024-04-25Published:
2024-05-22Contact:
Yongjun SHI通讯作者:
史永军Tantan SUN, Yongjun SHI. Research Progress of Factors Predicting Portal Vein Thrombosis[J]. Journal of ShanDong First Medical University&ShanDong Academy of Medical Sciences, 2024, 45(4): 251-256.
孙弹弹, 史永军. 门静脉血栓形成因素预测研究进展[J]. betway必威登陆网址 (betway.com )学报, 2024, 45(4): 251-256.
1 | Katsanos K, Al-Lamki SAM, Parthipun A, et al. Peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries[J].Cardiovasc Intervent Radiol,2017,40(3): 351. |
2 | Kimball AS, Obi AT, Diaz JA, et al. The emerging role of NETs in venous thrombosis and immunothrombosis[J].Front Immunol,2016,7: 236. |
3 | Guo L, Rondina MT. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases[J].Front Immunol,2019,10: 2204. |
4 | Driever EG, Magaz M, Adelmeijer J, et al. The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study[J].J Thromb Haemost,2022,20(9): 2075. |
5 | Driever EG, von Meijenfeldt FA, Adelmeijer J, et al. Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus[J].Hepatology,2022,75(4): 898. |
6 | Ren WH, Zhang J, Chen YY, et al. Evaluation of coagulation, fibrinolysis and endothelial biomarkers in cirrhotic patients with or without portal venous thrombosis[J].Clin Appl Thromb Hemost,2020,26: 1076029620982666. |
7 | O'Leary JG. Portal vein thrombosis prediction: rebalanced coagulation and rethinking anticoagulation[J].Liver Transpl,2019,25(12): 1741. |
8 | Lu SX, Hu GH, Chen SY, et al. Risk factors of portal vein thrombosis after devascularization treatment in patients with liver cirrhosis: a nested Case-Control study[J].Biomed Res Int,2020,2020: 9583706. |
9 | Serag WM, Mohammed B, Mohamed MM, et al. Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma[J].Heliyon,2020,6(8): e04677. |
10 | Noronha Ferreira C, Marinho RT, Cortez-Pinto H, et al. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study[J].Liver Int,2019,39(8): 1459. |
11 | Wu YY, Li HY, Zhang TS, et al. Splanchnic vein thrombosis in liver cirrhosis after splenectomy or splenic artery embolization: a systematic review and Meta-Analysis[J].Adv Ther,2021,38(4): 1904. |
12 | Zhang Y, Xu BY, Wang XB, et al. Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation[J].Clin Gastroenterol Hepatol,2020,18(11): 2564. |
13 | Ak C, Adali G, Sayar S, et al. Portal vein thrombosis risk factors in liver transplant candidates[J].Hepatol Forum,2022,3(3): 88. |
14 | Intagliata NM, Caldwell SH, Diagnosis TA. Development,and treatment of portal vein thrombosis in patients with and without cirrhosis[J].Gastroenterology,2019,156(6): 1582. |
15 | Stine JG, Wang J, Shah PM, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study[J].Liver Int,2018,38(1): 94. |
16 | Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol,2009,51(4): 682. |
17 | Under the Auspices of the Italian Association for the Study of liver diseases (AISF) and the italian society of internal medicine (SIMI). Hemostatic balance in patients with liver cirrhosis: report of a consensus conference[J].Dig Liver Dis,2016,48(5): 455. |
18 | Haidl H, Zöhrer E, Pohl S, et al. New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels[J].Pediatr Res,2019,86(6): 719. |
19 | Gatt A, Riddell A, Calvaruso V, et al. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy[J].J Thromb Haemost,2010,8(9): 1994. |
20 | Kalambokis GN, Oikonomou A, Baltayiannis G, et al. Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis[J].Hepatol Res,2016,46(3): E36. |
21 | Stine JG, Wang J, Shah PM, et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study[J].Liver Int,2018,38(1): 94. |
22 | Robertson B, Urquhart C, Ford I, et al. Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies[J].J Thromb Haemost,2007,5(8): 1679. |
23 | Turon F, Driever EG, Baiges A, et al. Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors[J].J Hepatol,2021,75(6): 1367. |
24 | Nicoară-Farcău O, Soy G, Magaz M, et al. New insights into the pathogenesis, risk factors, and treatment of portal vein thrombosis in patients with cirrhosis[J].Semin Thromb Hemost,2020,46(6): 673. |
25 | Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, et al. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians[J].J Thromb Thrombolysis,2017,44(3): 377. |
26 | Turco L, Garcia-Tsao G. Portal hypertension: pathogenesis and diagnosis[J].Clin Liver Dis,2019,23(4): 573. |
27 | Di Minno MND, Calcaterra I, Lupoli R, et al. Hemostatic changes in patients with COVID-19: a meta-analysis with meta-regressions[J].J Clin Med,2020,9(7): 2244. |
28 | Liu DW, Zhu YB, Chen W, et al. Relationship between the inflammation/immune indexes and deep venous thrombosis (DVT) incidence rate following tibial plateau fractures[J].J Orthop Surg Res,2020,15(1): 241. |
29 | Xing YY, Tian ZB, Jiang YP, et al. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis[J].Ann Med,2022,54(1): 302. |
30 | Zheng Z, Yu QS, Peng H, et al. Research on portal venous hemodynamics and influencing factors of portal vein system thrombosis for wilson's disease after splenectomy[J].Front Surg,2022,9: 834466. |
31 | Watters JM, Sambasivan CN, Zink K, et al. Splenectomy leads to a persistent hypercoagulable state after trauma[J].Am J Surg,2010,199(5): 646. |
32 | Kinjo N, Kawanaka H, Akahoshi T, et al. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension[J].Br J Surg,2010,97(6): 910. |
33 | Qi XS, Han GH, Ye C, et al. Splenectomy causes 10-Fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J].Med Sci Monit,2016,22: 2528. |
34 | Han JB, Shu QH, Zhang YF, et al. Predictive value of inflammation biomarkers in patients with portal vein thrombosis[J].J Clin Transl Hepatol,2021,9(3): 384. |
35 | Kushnir M, Cohen HW, Billett HH. Persistent neutrophilia is a marker for an increased risk of venous thrombosis[J].J Thromb Thrombolysis,2016,42(4): 545. |
36 | Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence of thrombosis?[J].Semin Thromb Hemost,2017,43(6): 553. |
37 | Hilscher MB, Sehrawat T, Arab JP, et al. Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension[J].Gastroenterology,2019,157(1): 193. |
38 | Pan JH, Wang L, Gao FB, et al. Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis[J].Eur J Intern Med,2022,104: 21. |
39 | Praktiknjo M, Trebicka J, Carnevale R, et al. Von willebrand and factor Ⅶ Ⅰ portosystemic circulation gradient in cirrhosis: implications for portal vein thrombosis[J].Clin Transl Gastroenterol,2020,11(2): e00123. |
40 | de Franchis R, Faculty BV. Revising consensus in portal hypertension: report of the Baveno Ⅴ consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol,2010,53(4): 762. |
41 | Xu XB, Guo XZ, De Stefano V, et al. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis[J].Hepatol Int,2019,13(4): 468. |
42 | Wu LF, Bai DS, Shi L, et al. Predictors of portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection in hepatitis B cirrhosis: a prospective study[J].Surg Endosc,2022,36(6): 4090. |
[1] | Bin LI, Feng FENG, Fulei LIU.Research progress on mechanism and correction strategy of tumor recurrence promoted by resection[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2023, 44(7): 535-540. |
[2] | Shuo WANG, Zuoqin ZHAO, Guquan ZHANG, Yongli ZHANG.Analgesic and anti-inflammatory effects of persimmon leaf flavone and its regulatory effects on p38MAPK and MMP2/9 in rats with oral ulcer[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2023, 44(3): 197-201. |
[3] | Jie LIAO, Yimei DU.Advances in the pathogenesis of postoperative atrial fibrillation[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(12): 891-896. |
[4] | Cuifang NIE, Chuanyun ZHAO, Shengqiang YANG.Therapeutic effect analysis of terlipressin combined with torvaptan in the treatment of hepatitis B cirrhosis complicated hepatorenal syndrome[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(10): 770-773. |
[5] | Shifeng HU.Analysis on predictive value of combined detection of serum MK and bFGF in predicting postoperative recurrence of patients with early gastric cancer[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(1): 45-49. |
[6] | Zhao Mengqiu, Ren Younan, Tao Shanjun, Zheng Shuguo.Effect ofsalvianolicacid B on improving myocardium injury in diabetic rats with blood glucose fluctuation[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(5): 369-374. |
[7] | ZHANG Xiao, GAO Yun, LI Xue-hua, TIAN Hong.The effect of fiberoptic bronchoscope suction and lavage treatment on patients with severe pneumonia and the effect of inflammation markers[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(3): 203-206. |
[8] | Qian Zhang, Shaoyan Huang, Lu yong Wang, Jianzhong Zhang.Influence mechanism of 6% hydroxyethyl starch 130/0.4 on protein leakage in patients with liver cirrhosis[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(12): 908-912. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||